NCT07070375View on ClinicalTrials.gov

Pharmacokinetics and Safety of HRS-8427 in Healthy Volunteers and in Patients With Impaired Renal Function

PHASE1CompletedINTERVENTIONAL

Enrollment

33

Participants

Timeline

Start Date

April 19, 2023

Primary Completion Date

August 23, 2023

Study Completion Date

August 23, 2023

Conditions

Gram-negative Bacterial Infections

Interventions

DRUG

HRS-8427

HRS-8427

Trial Locations (1)

200433

Huashan Hospital Fudan University, Shanghai

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY